Conference Call with Honasa Consumer Management and Analysts on Q1FY27 Performance and Outlook. Listen to the full earnings transcript.
Personal Products company Honasa Consumer announced Q1FY27 results Consolidated Financial Highlights: Revenue from Operations: The company reported revenue of Rs 7,559.46 million in Q1FY27, reflecting a growth of 26.99% YoY from Rs 5,952.54 million in Q1FY26 and an increase of 15.05% QoQ from Rs 6,570.84 million in Q4FY26. Total Income: Total income stood at Rs 7,784.57 million in Q1FY27, up 25.73% YoY compared to Rs 6,191.44 million in Q1FY26 and up 15.16% QoQ from Rs 6,759.62 million in Q4FY26. Profit Before Tax (PBT): For Q1FY27, PBT was Rs 1,192.44 million, marking a growth of 114.50% YoY from Rs 555.93 million in Q1FY26 and a 45.71% QoQ increase from Rs 818.37 million in Q4FY26. Profit After Tax (PAT): The company earned a PAT of Rs 904.48 million in Q1FY27, representing a significant YoY growth of 118.87% from Rs 413.25 million in Q1FY26 and a 30.26% QoQ growth from Rs 694.38 million in Q4FY26. Full Year Performance (FY26): For the full year ended March 31, 2026, the company recorded a total revenue from operations of Rs 23,919.42 million and a net profit after tax of Rs 2,001.90 million. Earnings Per Share (EPS): Basic EPS increased to Rs 2.77 in Q1FY27 from Rs 1.27 in Q1FY26 and Rs 2.13 in Q4FY26. Standalone Financial Highlights: Revenue from Operations: Standalone revenue for Q1FY27 was Rs 6,963.18 million, up 19.31% YoY from Rs 5,836.28 million in Q1FY26 and up 14.59% QoQ from Rs 6,076.48 million in Q4FY26. Total Income: Standalone total income for Q1FY27 was Rs 7,182.42 million, compared to Rs 6,070.12 million in Q1FY26 and Rs 6,254.09 million in Q4FY26. Profit Before Tax (PBT): Standalone PBT stood at Rs 1,112.46 million in Q1FY27, an increase of 106.69% YoY from Rs 538.24 million in Q1FY26 and a growth of 48.08% QoQ from Rs 751.23 million in Q4FY26. Profit After Tax (PAT): Standalone PAT for Q1FY27 was Rs 843.12 million, representing a YoY growth of 111.30% from Rs 399.01 million in Q1FY26 and a 30.77% QoQ growth from Rs 644.73 million in Q4FY26. Business Highlights: Segment-wise Performance: The Group is principally engaged in the trading of a variety of beauty and personal care products and related services. According to Ind AS 108, these activities constitute one single segment by the Chief Operating Decision Maker; hence, no separate segment disclosures are provided. Strategic Acquisition: On June 23, 2026, the Board approved the acquisition of a 58% equity stake (majority) in Fluence Pharma Private Limited, with the remaining 42% to be acquired in two tranches over the next 5-7 years. New Subsidiary Incorporation: The company approved the incorporation of a wholly-owned subsidiary, 'Honasa Health Private Limited,' to undertake business-to-consumer (B2C) operations for the company’s nutraceuticals business. It was incorporated on July 7, 2026. Legal Settlement: In a legal suit filed by overseas distributor RSM General Trading LLC, an arbitral tribunal passed a final award in favor of the Company. RSM was found to have breached the agreement and is liable to pay the Company approximately Rs 255.36 million (AED 9.92 million), along with interest. Dividend: The Board of Directors had previously recommended a final dividend of Rs 3/- per equity share (face value Rs 10/- each) on May 21, 2026, subject to shareholder approval. IPO Proceeds Utilization: As of June 30, 2026, the company has utilized Rs 3,208.34 million out of the net IPO proceeds of Rs 3,504.92 million. Major utilizations include Rs 1,820.00 million for advertisement expenses and Rs 1,218.92 million for general corporate purposes and unidentified inorganic acquisitions. Varun Alagh, Chairman and CEO & Co-founder, Honasa Consumer said: “We entered FY27 with a clear focus on building on the momentum we created in the second half of FY26, and Q1 has reinforced that the strategy is working. We delivered our highest-ever quarterly revenue and profit, with revenue growing ~32% and EBITDA more than doubling to Rs 110 crore. What stands out for us is that this growth is coming from both our core and younger brands. Our Focus Categories grew 35%+, and we are seeing stronger demand across General Trade, Modern Trade and eCommerce. This is the playbook we set out to build, and it is now translating into performance At the brand level, Mamaearth has accelerated to high-teens growth, led by its Focus Categories, while hero products such as Rice Dewy Bright Face Wash and Rosemary Anti-Hair Fall Shampoo are strongest growth drivers. The Derma Co. crossed INR 1,000 Cr in NSV ARR and entered the teens EBITDA club, making Honasa the only FMCG company in India to build two INR 1,000 Cr brands in the last ten years. Our Younger Brands continue to grow at 40%+. BTM Ventures has crossed Rs 150 crore ARR and is scaling beyond its South India stronghold into newer geographies and channels. For me, these are important signals that we are not reliant on any one brand or category; we are building a House of Brands where multiple brands have the potential to scale in their own right using our capabilities and repeatable playbooks. The next phase of this journey is about taking this strength into new categories. With FIKN, we enter fragrance with India’s first elixir brand, tapping into a large, underpenetrated category in India with potential to build a differentiated proposition. The focus is to build a future-ready House of Brands by staying close to the core, sharpening our category playbooks, and staying disciplined on capital allocation and talent density. At the heart of it, we want to keep building brands that solve real consumer needs and earn lasting consumer trust.” Result PDF